Global Oncothon 2026
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutated NSCLC After TKI Therapy
PRADO Trial: Neoadjuvant Ipilimumab Plus Nivolumab in Melanoma—5-Year Survival and Biomarker Analysis
Breakthrough Innovations in Frontline TNBC Care - The Breast Friends Podcast
Community Oncology Alliance Shares 2025 End of Year Update on Advocacy and Practice Support
In Memory of Kirsty Duncan: A Life Devoted to Science, Health, and Equity
Afreen Shariff Starts a New Position as Chair at ASCO for the ASPIRE Community of Practice
How the European Code Against Cancer Can Reduce Cancer Risk in Greece - ELLOK
The 2026 NCODA Global Oncology and Hematology Congress is a premier international gathering of oncology, hematology, and technology experts scheduled for March 11–12, 2026, in Dublin, Ireland. Organized by NCODA, the congress focuses on "bridging innovation and patient-centered care" through collaborative sessions that highlight best practices in medically integrated oncology. The technical program is designed […]
